Publication | Open Access

Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II study

Hematological MalignancyIndolent B-cell LymphomaProgression-free SurvivalLymphoid NeoplasiaMedicineMantle CellImmunologyHematologyPathologyImmunotherapyOncologyRadiation OncologyHealth Sciences